I think someone an editorial needs to review this article. There are a number of claims in here that are not clearly laid out.

When comparing the toxicities of Amanita and fentanyl, what exactly are you saying here? Are you saying that Amanita has a higher rate of death pers usage? Because I would say that that seems unlikely, but it certainly would need a citation.

At a moment when psychoactive mushrooms are being deregulated in the united states, it wouldn't make a lot of sense to regulate a substance that isn't particularly psychoactive.

Hospitalizations for cannabis use among inexperienced users doesn't mean the Cannabis is toxic, it means that sometimes people hospitalize themselves for anxiety. The person that is being described in this article is trying to treat her anxiety with amanita, got anxious, went to the hospital. I hardly think that this means Amanita needs to be more regulated. It probably means that women with anxiety need to get better attention and more appropriate guidance from their doctors. Especially in the United states.